432P Pembrolizumab (pembro) for previously treated, microsatellite instability–high (MSI-H)/mismatch repair–deficient (dMMR) metastatic colorectal cancer (mCRC): Final analysis of KEYNOTE-164

Subjects

Subjects :

Oncology
business.industry
Colorectal cancer
Cancer research
Medicine
Microsatellite instability
DNA mismatch repair
Hematology
Pembrolizumab
business
medicine.disease
Previously treated

Details

ISSN :

09237534

Volume :

32

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........c66ec554dea27d6ec1f917bbe0a24e1c

Full Text :

https://doi.org/10.1016/j.annonc.2021.08.953